{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:10:04Z","timestamp":1784257804773,"version":"3.55.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["NO.2022-CXTD-05"],"award-info":[{"award-number":["NO.2022-CXTD-05"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s10072-025-08051-8","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T08:14:51Z","timestamp":1739952891000},"page":"2393-2399","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["miRNAs in neurodegenerative diseases: from target screening to precision therapy"],"prefix":"10.1007","volume":"46","author":[{"given":"Dongyi","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"issue":"5","key":"8051_CR1","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1093\/bib\/bby054","volume":"20","author":"L Chen","year":"2019","unstructured":"Chen L, Heikkinen L, Wang C, Yang Y, Sun H, Wong G (2019) Trends in the development of miRNA bioinformatics tools. Brief Bioinform 20(5):1836\u20131852","journal-title":"Brief Bioinform"},{"key":"8051_CR2","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.bbadis.2016.06.001","volume":"1862","author":"S Kumar","year":"2016","unstructured":"Kumar S, Reddy PH (2016) Are circulating microRNAs peripheral biomarkers for Alzheimer\u2019s disease? Biochim Biophys Acta 1862:1617\u20131627","journal-title":"Biochim Biophys Acta"},{"key":"8051_CR3","doi-asserted-by":"crossref","unstructured":"Lu TX, Rothenberg ME, MicroRNA (2018) J Allergy Clin Immunol 141(4):1202\u20131207","DOI":"10.1016\/j.jaci.2017.08.034"},{"issue":"13","key":"8051_CR4","doi-asserted-by":"publisher","first-page":"7167","DOI":"10.3390\/ijms23137167","volume":"23","author":"PTB Ho","year":"2022","unstructured":"Ho PTB, Clark IM, Le LTT (2022) MicroRNA-Based diagnosis and therapy. Int J Mol Sci 23(13):7167","journal-title":"Int J Mol Sci"},{"key":"8051_CR5","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1073\/pnas.1112427109","volume":"109","author":"Y Kawahara","year":"2012","unstructured":"Kawahara Y, Mieda-Sato A (2012) TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Proc Natl Acad Sci USA 109:3347\u20133352","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"8051_CR6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/s12951-022-01724-y","volume":"20","author":"W Xiong","year":"2022","unstructured":"Xiong W, Li C, Kong G, Zeng Q, Wang S, Yin G, Gu J, Fan J (2022) Treg cell-derived exosomes miR-709 attenuates microglia pyroptosis and promotes motor function recovery after spinal cord injury. J Nanobiotechnol 20(1):529","journal-title":"J Nanobiotechnol"},{"key":"8051_CR7","doi-asserted-by":"publisher","first-page":"14645","DOI":"10.1523\/JNEUROSCI.1327-13.2013","volume":"33","author":"S Absalon","year":"2013","unstructured":"Absalon S, Kochanek DM, Raghavan V, Krichevsky AM (2013) MiR-26b, upregulated in Alzheimer\u2019s disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons. J Neurosci 33:14645\u201314659","journal-title":"J Neurosci"},{"key":"8051_CR8","doi-asserted-by":"crossref","unstructured":"Yang DS, Stavrides P, Mohan PS, Kaushik S, Kumar A, Ohno M, Schmidt SD, Wesson D, Bandyopadhyay U, Jiang Y et al (2011) Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer\u2019s disease ameliorates amyloid pathologies and memory deficits.Brain. 134:258\u2013277","DOI":"10.1093\/brain\/awq341"},{"key":"8051_CR9","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1080\/15548627.2018.1522467","volume":"15","author":"Y Li","year":"2019","unstructured":"Li Y, Zhou D, Ren Y, Zhang Z, Guo X, Ma M, Xue Z, Lv J, Liu H, Xi Q et al (2019) MiR-223 restrains autophagy and promotes CNS inflammation by targeting ATG16L1. Autophagy 15:478\u2013492","journal-title":"Autophagy"},{"key":"8051_CR10","doi-asserted-by":"publisher","first-page":"116899","DOI":"10.1016\/j.biopha.2024.116899","volume":"177","author":"Z Alkhazaali-Ali","year":"2024","unstructured":"Alkhazaali-Ali Z, Sahab-Negah S, Boroumand AR, Tavakol-Afshari J (2024) MicroRNA (miRNA) as a biomarker for diagnosis, prognosis, and therapeutics molecules in neurodegenerative disease. Biomed Pharmacother 177:116899","journal-title":"Biomed Pharmacother"},{"key":"8051_CR11","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.3390\/cells9061443","volume":"9","author":"M Serpente","year":"2020","unstructured":"Serpente M, Fenoglio C, D\u2019Anca M, Arcaro M, Sorrentino F, Visconte C, Arighi A, Fumagalli GG, Porretti L, Cattaneo A et al (2020) MiRNA Profiling in plasma neural-derived small extracellular vesicles from patients with Alzheimer\u2019s Disease. Cells 9:1443","journal-title":"Cells"},{"issue":"12","key":"8051_CR12","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.2217\/bmm-2018-0341","volume":"13","author":"YH Zhang","year":"2019","unstructured":"Zhang YH, Bai SF, Yan JQ (2019) Blood circulating miRNAs as biomarkers of Alzheimer\u2019s disease: a systematic review and meta-analysis. Biomark Med 13(12):1045\u20131054","journal-title":"Biomark Med"},{"issue":"9","key":"8051_CR13","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/nn.4608","volume":"20","author":"A Caccamo","year":"2017","unstructured":"Caccamo A, Branca C, Piras IS, Ferreira E, Huentelman MJ, Liang WS, Oddo S (2017) Necroptosis activation in Alzheimer\u2019s disease. Nat Neurosci 20(9):1236\u20131246","journal-title":"Nat Neurosci"},{"issue":"2","key":"8051_CR14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00401-010-0756-0","volume":"121","author":"WX Wang","year":"2011","unstructured":"Wang WX, Huang Q, Hu Y, Stromberg AJ, Nelson PT (2011) Patterns of microRNA expression in normal and early Alzheimer\u2019s disease human temporal cortex: white matter versus gray matter. Acta Neuropathol 121(2):193\u2013205","journal-title":"Acta Neuropathol"},{"issue":"10","key":"8051_CR15","doi-asserted-by":"publisher","first-page":"e0185989","DOI":"10.1371\/journal.pone.0185989","volume":"12","author":"I Morales","year":"2017","unstructured":"Morales I, Sanchez A, Rodriguez-Sabate C, Rodriguez M (2017) Striatal astrocytes engulf dopaminergic debris in Parkinson\u2019s disease: a study in an animal model. PLoS ONE 12(10):e0185989","journal-title":"PLoS ONE"},{"issue":"1","key":"8051_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/nm0103-3","volume":"9","author":"LB Yang","year":"2003","unstructured":"Yang LB, Lindholm K, Yan R, Citron M, Xia W, Yang XL, Beach T, Sue L, Wong P, Price D, Li R, Shen Y (2003) Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat Med 9(1):3\u20134","journal-title":"Nat Med"},{"key":"8051_CR17","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/s41419-019-2039-6","volume":"10","author":"C Yan","year":"2019","unstructured":"Yan C, Liu J, Gao J, Sun Y, Zhang L, Song H, Xue L, Zhan L, Gao G, Ke Z et al (2019) IRE1 promotes neurodegeneration through autophagy-dependent neuron death in the Drosophila model of Parkinson\u2019s disease. Cell Death Dis 10:800","journal-title":"Cell Death Dis"},{"issue":"5","key":"8051_CR18","doi-asserted-by":"publisher","first-page":"6891","DOI":"10.3390\/molecules19056891","volume":"19","author":"M Grasso","year":"2014","unstructured":"Grasso M, Piscopo P, Confaloni A, Denti MA (2014) Circulating miRNAs as biomarkers for neurodegenerative disorders. Molecules 19(5):6891\u20136910","journal-title":"Molecules"},{"issue":"22","key":"8051_CR19","doi-asserted-by":"publisher","first-page":"5649","DOI":"10.3390\/ijms20225649","volume":"20","author":"SY Goh","year":"2019","unstructured":"Goh SY, Chao YX, Dheen ST, Tan EK, Tay SS (2019) Role of MicroRNAs in Parkinson\u2019s Disease. Int J Mol Sci 20(22):5649","journal-title":"Int J Mol Sci"},{"key":"8051_CR20","doi-asserted-by":"crossref","unstructured":"Xie J, Burt DR, Gao G (2015) Adeno-associated virus-mediated microRNA delivery and therapeutics. Semin Liver Dis. 35(1):81\u2013\u20098. doi: 10.1055\/s-0034-1397352. Epub 2015 Jan 29. PMID: 25632938; PMCID: PMC4460833","DOI":"10.1055\/s-0034-1397352"},{"key":"8051_CR21","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.nbd.2011.12.046","volume":"46","author":"MM Mouradian","year":"2012","unstructured":"Mouradian MM (2012) MicroRNAs in Parkinson\u2019s disease. Neurobiol Dis 46:279\u2013284. https:\/\/doi.org\/10.1016\/j.nbd.2011.12.046","journal-title":"Neurobiol Dis"},{"key":"8051_CR22","unstructured":"Xie N, Qi J, Li S, Deng J, Chen Y Y. Lian Upregulated lncRNA small nucleolar RNA host gene 1 promotes 1-methyl-4-phenylpyridinium ion-induced cytotoxicity and reactive oxygen species production through miR-15b-5p\/GSK3\u03b2 axis in human dopaminergic SH-SY5Y cells"},{"key":"8051_CR23","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1093\/cercor\/bhq262","volume":"21","author":"P Gaughwin","year":"2011","unstructured":"Gaughwin P, Ciesla M, Yang H, Lim B, Brundin P (2011) Stage-specific modulation of cortical neuronal development by Mmu-miR-134. Cereb Cortex 21:1857\u20131869","journal-title":"Cereb Cortex"},{"key":"8051_CR24","doi-asserted-by":"publisher","first-page":"9164","DOI":"10.1073\/pnas.1903646116","volume":"116","author":"JL Liu","year":"2019","unstructured":"Liu JL, He JP, Zhu C, Cheng HZ (2019) Endometrial carcinoma may favor partial, but not complete, loss of the TGF-\u03b2 signaling pathway. Proc Natl Acad Sci USA 116:9164\u20139165","journal-title":"Proc Natl Acad Sci USA"},{"key":"8051_CR25","doi-asserted-by":"publisher","first-page":"2591248","DOI":"10.1155\/2020\/2591248","volume":"2020","author":"CC Yu","year":"2020","unstructured":"Yu CC, Chen HL, Chen MH, Lu CH, Tsai NW, Huang CC, Chang YY, Li SH, Chen YS, Chiang PL, Lin WC (2020) Vascular inflammation is a risk factor Associated with Brain Atrophy and Disease Severity in Parkinson\u2019s Disease: a case-control study. Oxid Med Cell Longev 2020:2591248","journal-title":"Oxid Med Cell Longev"},{"key":"8051_CR26","doi-asserted-by":"publisher","first-page":"148829","DOI":"10.1016\/j.gene.2024.148829","volume":"931","author":"S Mm Yahya","year":"2024","unstructured":"Mm Yahya S, Elsayed GH (2024) The role of MiRNA-34 family in different signaling pathways and its therapeutic options. Gene 931:148829","journal-title":"Gene"},{"issue":"2","key":"8051_CR27","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ajhg.2007.09.021","volume":"82","author":"G Wang","year":"2008","unstructured":"Wang G, van der Walt JM, Mayhew G, Li YJ, Z\u00fcchner S, Scott WK, Martin ER, Vance JM (2008) Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. Am J Hum Genet 82(2):283\u2013289","journal-title":"Am J Hum Genet"},{"issue":"11","key":"8051_CR28","doi-asserted-by":"publisher","first-page":"9547","DOI":"10.3390\/ijms24119547","volume":"24","author":"E Paccosi","year":"2023","unstructured":"Paccosi E, Proietti-De-Santis L (2023) Parkinson\u2019s Disease: from Genetics and epigenetics to Treatment, a miRNA-Based strategy. Int J Mol Sci 24(11):9547","journal-title":"Int J Mol Sci"},{"issue":"3","key":"8051_CR29","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.nbd.2011.01.029","volume":"42","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L, Seow Y, Schapira AH, Gardiner C, Sargent IL, Wood MJ, Cooper JM (2011) Lysosomal dysfunction increases exo-some-mediated alpha-synuclein release and transmission. Neurobiol Dis 42(3):360\u2013367","journal-title":"Neurobiol Dis"},{"key":"8051_CR30","doi-asserted-by":"publisher","first-page":"8537296","DOI":"10.1155\/2023\/8537296","volume":"2023","author":"YM Ma","year":"2023","unstructured":"Ma YM, Zhao L (2023) Mechanism and therapeutic Prospect of miRNAs in neurodegenerative diseases. Behav Neurol 2023:8537296. https:\/\/doi.org\/10.1155\/2023\/8537296","journal-title":"Behav Neurol"},{"issue":"2","key":"8051_CR31","doi-asserted-by":"publisher","first-page":"122","DOI":"10.2174\/0115665232261931231006103234","volume":"24","author":"A Saleem","year":"2024","unstructured":"Saleem A, Javed M, Akhtar MF, Sharif A, Akhtar B, Naveed M, Saleem U, Baig MMFA, Zubair HM, Bin Emran T, Saleem M, Ashraf GM (2024) Current updates on the role of MicroRNA in the diagnosis and treatment of neurodegenerative diseases. Curr Gene Ther 24(2):122\u2013134","journal-title":"Curr Gene Ther"},{"key":"8051_CR32","doi-asserted-by":"publisher","first-page":"12726","DOI":"10.1074\/jbc.M109.086827","volume":"285","author":"E Doxakis","year":"2010","unstructured":"Doxakis E (2010) Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153. J Biol Chem 285:12726\u201312734","journal-title":"J Biol Chem"},{"key":"8051_CR33","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.neuroscience.2018.03.016","volume":"379","author":"H Wei","year":"2018","unstructured":"Wei H, Xu Y, Xu W, Zhou Q, Chen Q, Yang M, Feng F, Liu Y, Zhu X, Yu M et al (2018) Serum exosomal miR-223 serves as a potential Diagnostic and Prognostic Biomarker for Dementia. Neuroscience 379:167\u2013176","journal-title":"Neuroscience"},{"key":"8051_CR34","doi-asserted-by":"crossref","unstructured":"Wang H, MicroRNAs (2021) Multiple sclerosis, and Depression. Int J Mol Sci 22(15):7802","DOI":"10.3390\/ijms22157802"},{"key":"8051_CR35","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.celrep.2019.09.020","volume":"29","author":"A Tripathi","year":"2019","unstructured":"Tripathi A, Volsko C, Garcia JP, Agirre E, Allan KC, Tesar PJ et al (2019) Oligodendrocyte intrinsic miR-27a controls myelination and remyelination. Cell Rep 29:904\u2013919e9","journal-title":"Cell Rep"},{"key":"8051_CR36","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/ana.24931","volume":"81","author":"I Selmaj","year":"2017","unstructured":"Selmaj I, Cichalewska M, Namiecinska M, Galazka G, Horzelski W, Selmaj KW et al (2017) Global exosome transcriptome profiling reveals biomarkers for multiple sclerosis. Ann Neurol 81:703\u2013717","journal-title":"Ann Neurol"},{"key":"8051_CR37","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.it.2005.07.004","volume":"26","author":"B Engelhardt","year":"2005","unstructured":"Engelhardt B, Ransohoff RM (2005) The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol 26:485\u2013495","journal-title":"Trends Immunol"},{"issue":"1\u20132","key":"8051_CR38","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jneuroim.2011.10.006","volume":"248","author":"M Guerau-de-Arellano","year":"2012","unstructured":"Guerau-de-Arellano M, Alder H, Ozer HG, Lovett-Racke A, Racke MK (2012) miRNA profiling for biomarker discovery in multiple sclerosis: from microarray to deep sequencing. J Neuroimmunol 248(1\u20132):32\u201339","journal-title":"J Neuroimmunol"},{"key":"8051_CR39","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3389\/fneur.2020.00132","volume":"11","author":"Z Zhou","year":"2020","unstructured":"Zhou Z, Xiong H, Xie F, Wu Z, Feng Y (2020) A Meta-Analytic Review of the value of miRNA for multiple sclerosis diagnosis. Front Neurol 11:132","journal-title":"Front Neurol"},{"key":"8051_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep34503","volume":"6","author":"D Lecca","year":"2016","unstructured":"Lecca D, Marangon D, Coppolino GT, Mendez AM, Finardi A, Dalla Costa G, Martinelli V, Furlan R, Abbracchio MP (2016) MiR-125a-3p timely inhibits oligodendroglial maturation and is pathologically up-regulated in human multiple sclerosis. Sci Rep 6:1\u201312","journal-title":"Sci Rep"},{"key":"8051_CR41","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1126\/science.1181046","volume":"326","author":"AH Williams","year":"2009","unstructured":"Williams AH, Valdez G, Moresi V, Qi X, McAnally J, Elliott JL, Bassel-Duby R, Sanes JR, Olson EN (2009) MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 326:1549\u20131554","journal-title":"Science"},{"issue":"5","key":"8051_CR42","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1242\/dmm.028613","volume":"10","author":"EY Liu","year":"2017","unstructured":"Liu EY, Cali CP, Lee EB (2017) RNA metabolism in neurodegenerative disease. Dis Model Mech 10(5):509\u2013518","journal-title":"Dis Model Mech"},{"key":"8051_CR43","doi-asserted-by":"publisher","first-page":"101803","DOI":"10.1016\/j.pneurobio.2020.101803","volume":"190","author":"A Loffreda","year":"2020","unstructured":"Loffreda A, Nizzardo M, Arosio A, Ruepp MD, Calogero RA, Volinia S, Galasso M, Bendotti C, Ferrarese C, Lunetta C, Rizzuti M, Ronchi AE, M\u00fchlemann O, Tremolizzo L, Corti S, Barabino SML (2020) miR-129-5p: a key factor and therapeutic target in amyotrophic lateral sclerosis. Prog Neurobiol 190:101803","journal-title":"Prog Neurobiol"},{"issue":"1","key":"8051_CR44","doi-asserted-by":"publisher","first-page":"102147","DOI":"10.1016\/j.omtn.2024.102147","volume":"35","author":"C Duan","year":"2024","unstructured":"Duan C, Kang M, Pan X, Gan Z, Huang V, Li G, Place RF, Li LC (2024) Intrathecal administration of a novel siRNA modality extends survival and improves motor function in the SOD1G93A ALS mouse model. Mol Ther Nucleic Acids 35(1):102147","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"8051_CR45","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s12017-024-08773-6","volume":"26","author":"A Musar\u00f2","year":"2024","unstructured":"Musar\u00f2 A, Dobrowolny G, Cambieri C, Libonati L, Moret F, Casola I, Laurenzi G, Garibaldi M, Inghilleri M, Ceccanti M (2024) MiR206 and 423-3p are differently modulated in fast and slow-progressing amyotrophic lateral sclerosis patients. Neuromolecular Med 26(1):5","journal-title":"Neuromolecular Med"},{"key":"8051_CR46","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.neurobiolaging.2017.03.027","volume":"55","author":"R Waller","year":"2017","unstructured":"Waller R, Goodall EF, Milo M, Cooper-Knock J, Da Costa M, Hobson E et al (2017) Serum miRNAs miR-206, 143-3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS). Neurobiol Aging 55:123\u2013131","journal-title":"Neurobiol Aging"},{"key":"8051_CR47","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s10048-014-0420-2","volume":"15","author":"B De Felice","year":"2014","unstructured":"De Felice B, Annunziata A, Fiorentino G, Borra M, Biffali E, Coppola C et al (2014) Mir-338-3p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients. Neurogenetics 15:243\u2013253. https:\/\/doi.org\/10.1007\/s10048-014-0420-2","journal-title":"Neurogenetics"},{"key":"8051_CR48","doi-asserted-by":"publisher","first-page":"739016","DOI":"10.3389\/fnmol.2021.739016","volume":"14","author":"TW Lo","year":"2021","unstructured":"Lo TW, Figueroa-Romero C, Hur J et al (2021) Extracellular vesicles in serum and central nervous system tissues contain microRNA signatures in sporadic amyotrophic lateral sclerosis. Front Mol Neurosci 14:739016","journal-title":"Front Mol Neurosci"},{"key":"8051_CR49","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1093\/brain\/awt164","volume":"136","author":"G Bruneteau","year":"2013","unstructured":"Bruneteau G, Simonet T, Bauch\u00e9 S et al (2013) Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression. Brain 136:2359\u20132368","journal-title":"Brain"},{"key":"8051_CR50","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.gene.2012.07.058","volume":"508","author":"B De Felice","year":"2012","unstructured":"De Felice B, Guida M, Coppola C, De Mieri G, Cotrufo R (2012) A miRNA signature in leukocytes from sporadic amyotrophic lateral sclerosis. Gene 508:35\u201340","journal-title":"Gene"},{"issue":"24","key":"8051_CR51","doi-asserted-by":"publisher","first-page":"e2105442","DOI":"10.1002\/advs.202105442","volume":"9","author":"Z Yu","year":"2022","unstructured":"Yu Z, Fang X, Liu W, Sun R, Zhou J, Pu Y, Zhao M, Sun D, Xiang Z, Liu P, Ding Y, Cao L, He C (2022) Microglia regulate blood-brain Barrier Integrity via MiR-126a-5p\/MMP9 Axis during Inflammatory Demyelination. Adv Sci (Weinh) 9(24):e2105442","journal-title":"Adv Sci (Weinh)"},{"issue":"2","key":"8051_CR52","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.pharmthera.2011.10.002","volume":"133","author":"E Junn","year":"2012","unstructured":"Junn E, Mouradian MM (2012) MicroRNAs in neurodegenerative diseases and their therapeutic potential. Pharmacol Ther 133(2):142\u2013150","journal-title":"Pharmacol Ther"},{"key":"8051_CR53","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/978-1-4939-8982-9_9","volume":"1912","author":"I Monga","year":"2019","unstructured":"Monga I, Kumar M (2019) Computational resources for prediction and analysis of functional miRNA and their Targetome. Methods Mol Biol 1912:215\u2013250","journal-title":"Methods Mol Biol"},{"issue":"10","key":"8051_CR54","doi-asserted-by":"publisher","first-page":"5954","DOI":"10.1007\/s12035-023-03446-0","volume":"60","author":"D Bhatnagar","year":"2023","unstructured":"Bhatnagar D, Ladhe S, Kumar D (2023) Discerning the prospects of miRNAs as a Multi-target Therapeutic and Diagnostic for Alzheimer\u2019s Disease. Mol Neurobiol 60(10):5954\u20135974","journal-title":"Mol Neurobiol"},{"issue":"1","key":"8051_CR55","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10571-024-01522-0","volume":"45","author":"C Chang","year":"2024","unstructured":"Chang C, Weiping L, Jibing C (2024) Exosomal MiRNA Therapy for Central Nervous System Injury diseases. Cell Mol Neurobiol 45(1):3","journal-title":"Cell Mol Neurobiol"},{"key":"8051_CR56","doi-asserted-by":"crossref","unstructured":"Cell-free (2016) 3D scaffold with two-stage delivery of miRNA-26a to regenerate critical-sized bone defects Nat. Commun. 7:10376 miRNA","DOI":"10.1038\/ncomms10376"},{"key":"8051_CR57","doi-asserted-by":"crossref","unstructured":"Dasgupta I, Chatterjee A (2021) Recent advances in miRNA delivery systems Methods Protoc. 4:10","DOI":"10.3390\/mps4010010"},{"issue":"4","key":"8051_CR58","doi-asserted-by":"publisher","first-page":"dmm047662","DOI":"10.1242\/dmm.047662","volume":"14","author":"M Hill","year":"2021","unstructured":"Hill M, Tran N (2021) miRNA interplay: mechanisms and consequences in cancer. Dis Model Mech 14(4):dmm047662","journal-title":"Dis Model Mech"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08051-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08051-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08051-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T07:03:25Z","timestamp":1747379005000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08051-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["8051"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08051-8","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,19]]},"assertion":[{"value":"20 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not require an ethics statement.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This article has no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}